AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

783.163

-9.888-1.25%

Number of Gainers:8

Number of Losers:22

Number of Flat:16

PE:- -

High:793.095

Open:793.093

Low:782.162

Close:793.051

Loading ...

Neuren Pharmaceuticals Confirms Primary Endpoints for Phase Three Phelan-McDermid Syndrome Drug Candidate Trial

MT Newswires Live

Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

BRIEF-Botanix Pharmaceuticals Seeks Trading Halt

A bull market could be coming for ASX shares! Here's what I'm buying

Insider Buyers Lose AU$40k As Monash IVF Group Sheds AU$142m

Simply Wall St.

Aerospace Industry Faces Risks of Supply Chain Disruption Amid High Tariffs, Morgan Stanley Says

MT Newswires Live

Australian Shares End Week Lower; Monash IVF Group Confirms Brisbane Clinic Embryo Mix-Up

MT Newswires Live

Australian shares end week in the red as tariff blitz dents sentiment

Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today

ASX Biggest Losers

MT Newswires Live

Australia's Monash IVF admits 'error' after woman gives birth in embryo swap

BRIEF-Mayne Pharma Served With Legal Proceeding Filed Against One Of Its US Subsidiaries

BUZZ-Australia's Monash IVF drops after embryo mix-up in clinic

Hearts and Minds Investments Portfolio Falls Nearly 9% in March

MT Newswires Live

Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center

MT Newswires Live

Mayne Pharma Group Served With Legal Proceedings Against US Unit

MT Newswires Live

Mayne Pharma Group - Proceeding Is Brought by TherapeuticsMD, Inc. (Txmd) as Plaintiff

THOMSON REUTERS

Mayne Pharma - Served With Legal Proceeding Filed Against One of Its US Subsidiaries, Mayne Pharma Llc, in United States District Court

THOMSON REUTERS

Mayne Pharma Group - Proceeding Alleges Breach of Contract, Others

THOMSON REUTERS

Immuron Travelan® Highest Sales in History

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":783.16254,"timestamp":1745301599986,"preClose":793.05054,"halted":0,"volume":66212972,"delay":0,"changeRate":-0.012468,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-9.888,"latestTime":"04-22 16:00:00 AEST","open":793.0932,"high":793.0951,"low":782.16187,"amount":297259232,"amplitude":0.013786,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745280000000,1745301600000]],"turnoverRate":0.001795,"increases":7,"decrements":20,"flats":16,"marketCap":123703500651.625,"floatMarketCap":121201824994.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":793.0951,"amplitude":0.013786,"preClose":793.05054,"low":782.16187,"latestPrice":783.16254,"volume":66212972,"delay":0,"open":793.0932,"prevYearClose":936.801,"prevWeekClose":793.051,"prevMonthClose":815.605,"prevQuarterClose":815.605,"fiveDayClose":769.762,"twentyDayClose":833.755,"sixtyDayClose":904.08,"secType":"PLATE","market":"AU","turnoverRate":0.001795,"marketCap":123703500651.625,"floatMarketCap":121201824994.75,"timestamp":1745301599986,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":22,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527912381","title":"Neuren Pharmaceuticals Confirms Primary Endpoints for Phase Three Phelan-McDermid Syndrome Drug Candidate Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527912381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527912381?lang=en_us&edition=fundamental","pubTime":"2025-04-14 08:40","pubTimestamp":1744591233,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  reported that primary endpoints for its planned single phase-three clinical trial of its drug candidate NNZ-2591 as a treatment for Phelan-McDermid syndrome were confirmed at a meeting with the US Food and Drug Administration, according to a Monday Australian bourse filing.The co-primary endpoints in the double-blind placebo-controlled study of treatment for 13 weeks will be the change from baseline in the receptive communication sub-domain of the Vineland adaptivebehavior scales, third edition, and the overall score in the Phelan-McDermid syndrome assessment of change.The firm said it remains on track to commence the phase three trial by the middle of the year, subject to regulatory review of the final version of the trial protocol.Both measures included in the primary endpoints showed clinically meaningful improvement in the firm's phase two open-label clinical trial, the filing noted.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","NEU.AU","BK7508"],"gpt_icon":0},{"id":"2527140929","title":"Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527140929","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527140929?lang=en_us&edition=fundamental","pubTime":"2025-04-14 07:49","pubTimestamp":1744588166,"startTime":"0","endTime":"0","summary":"CSL  has had a rough three months with its share price down 17%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Particularly, we will be paying attention to CSL's  ROE today.Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. What is CSL worth today?The  intrinsic value infographic in our free research report  helps visualize whether CSL is currently mispriced by the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/csl-limiteds-asx-csl-fundamentals-234926416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["SG9999004303.SGD","BK7511","BK7501","BK7508","BK7067","LU1169590202.USD","SGXZ23171101.USD","CSL.AU","CSL","LU0728928796.USD","BK4086","LU1169589451.USD"],"gpt_icon":0},{"id":"2527916812","title":"BRIEF-Botanix Pharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2527916812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527916812?lang=en_us&edition=fundamental","pubTime":"2025-04-14 07:41","pubTimestamp":1744587700,"startTime":"0","endTime":"0","summary":"BRIEF-Botanix Pharmaceuticals Seeks Trading HaltApril 14 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250413:nFWN3QQ05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7096","BK7508","BOT.AU"],"gpt_icon":0},{"id":"2527353279","title":"A bull market could be coming for ASX shares! Here's what I'm buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2527353279","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527353279?lang=en_us&edition=fundamental","pubTime":"2025-04-13 04:11","pubTimestamp":1744488660,"startTime":"0","endTime":"0","summary":"I'll be looking to top up my positions in companies I already know and trust — names that have delivered for years and still have plenty of growth ahead. That includes:  CSL Ltd  – A global biotech leader with an enviable R&D pipeline and unmatched plasma network. Lovisa Holdings Ltd  – A fast-fashion jewellery success story with an expanding global footprint and excellent store-level economics. WiseTech Global Ltd  – A logistics tech giant with a long runway and dominant platform in the freight space. VanEck Morningstar Wide Moat ETF  – A curated portfolio of US companies with durable competitive advantages. Betashares Nasdaq 100 ETF  – Exposure to the world's biggest and most innovative tech names, now trading at more attractive prices.  Because whether we're already in the early stages of a new bull market — or just getting ready to turn the page — these are the kinds of investments I want leading the charge. Not just for the next few months, but for the long haul.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/13/a-bull-market-could-be-coming-for-asx-shares-heres-what-im-buying/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7503","LOV.AU","MOAT.AU","WTC.AU","BK7508","CSL.AU","NDQ.AU","BK7128","BK7067","BK7511","BK7016","BK7501"],"gpt_icon":0},{"id":"2526536626","title":"Insider Buyers Lose AU$40k As Monash IVF Group Sheds AU$142m","url":"https://stock-news.laohu8.com/highlight/detail?id=2526536626","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526536626?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:55","pubTimestamp":1744404944,"startTime":"0","endTime":"0","summary":"Insiders who acquired AU$93.3k worth of Monash IVF Group Limited's ( ASX:MVF ) stock at an average price of AU$1.21 in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-mvf/monash-ivf-group-shares/news/insider-buyers-lose-au40k-as-monash-ivf-group-sheds-au142m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1670711040.USD","BK4504","BK4588","BK4202","BK7508","VFC","LU1670710588.SGD","BK7113","LU1670711123.USD","LU1670710661.SGD","MVF.AU"],"gpt_icon":0},{"id":"2526699112","title":"Aerospace Industry Faces Risks of Supply Chain Disruption Amid High Tariffs, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526699112","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526699112?lang=en_us&edition=fundamental","pubTime":"2025-04-11 22:49","pubTimestamp":1744382977,"startTime":"0","endTime":"0","summary":"The aerospace industry faces risks to its already vulnerable and complex supply chains amid US tariff increases, Morgan Stanley said in a Friday research note.Analysts said they prefer aftermarket names over OE as pricing power and pass-through clauses remain the top \"mitigants\" to tariffs.Although demand destruction in the aerospace industry will be relatively less disruptive than Covid, risks of similar supply chain issues will likely arise.The aerospace sector is undersupplied, and airlines might further delay taking aircraft delivery due to tariffs, the brokerage said.Signs of weakness in both domestic and international air traffic emerge amid a volatile macro backdrop stemming from dynamic US trade policies, according to the analysts.Morgan Stanley said that Transidgm  and RBC Bearings  have robust pricing power and can dynamically adjust pricing. Analysts said they downgraded Joby Aviation  to equal weight from overweight.The brokerage lowered its price target for Joby Aviation t","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0106261372.USD","LU0109981661.USD","LU0795875086.SGD","LU0320765646.SGD","LU0158827948.USD","LU2133065610.SGD","IE00B64QTZ34.USD","BK7002","LU2271345857.HKD","IE00BKVL7J92.USD","LU0912757837.SGD","BK4585","LU2089284900.SGD","RBC","TDG","BK4127","AER","MS","CAE.AU","LU0225283273.USD","BK4516","BK7508","LU0240878834.USD","LU0267386448.USD","AER.AU","LU2065731478.USD","LU1989772923.USD","LU1363072403.SGD","TXT","LU0053671581.USD","BK4161","LU1162221912.USD","BK4008","LU0314104364.USD","FTAI","LU0006306889.USD","LU1720051108.HKD","HXL.AU","CAE","HXL","LU0158827781.USD","LU0390134368.USD","LU0205193047.USD","BK7067","LU2347655156.SGD","JOBY","LU0098860793.USD","IE00BLDYK493.USD","LU1668664300.SGD","BK4588"],"gpt_icon":0},{"id":"2526869436","title":"Australian Shares End Week Lower; Monash IVF Group Confirms Brisbane Clinic Embryo Mix-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2526869436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526869436?lang=en_us&edition=fundamental","pubTime":"2025-04-11 14:47","pubTimestamp":1744354074,"startTime":"0","endTime":"0","summary":"Australian shares closed the week lower, as Trump raised tariffs on China.The S&P/ASX 200 Index fell 0.82% or 63.1 points to close at 7,646.5.President Trump raised tariffs on China to 125%, triggering a global market sell-off as investors sought safe havens amid fears of retaliatory action from Beijing, Bloomberg reported.\"The Trump administration's stance has evolved from an all-out trade war against everyone to a concentrated trade war against China,\" said Nicolas Oudin of Gavekal Research.On the domestic front, Australia's financial system is \"strong and well placed to absorb shocks from abroad,\" Reserve Bank Governor Michele Bullock said in a speech in Melbourne.In company news, Monash IVF Group  confirmed that an embryo was mistakenly implanted into the wrong patient at its Brisbane clinic, resulting in the birth of a child. Shares of the company fell 36% at market close.Dexus  lost its appeal against Macquarie Group's Macquarie Retail's pre-emption rights to acquire the company'","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4202","MQG.AU","BK7511","MVF.AU","BK7040","BK7508","XKO.AU","BK7122","BK4585","LU1670710588.SGD","LU1670711040.USD","XAO.AU","BK4588","BK7154","WOW.AU","BK7510","DXS.AU","BK4504","BK7501","BK7113","BK7046","VFC","LU1670711123.USD","XJO.AU","LU1670710661.SGD"],"gpt_icon":0},{"id":"2526817686","title":"Australian shares end week in the red as tariff blitz dents sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526817686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526817686?lang=en_us&edition=fundamental","pubTime":"2025-04-11 14:38","pubTimestamp":1744353530,"startTime":"0","endTime":"0","summary":"Australian shares end week in the red as tariff blitz dents sentimentAXJO falls 0.3% in the weekHealth stocks post worst week since mid-February Energy stocks down 1.8%Updates to closeBy Rajasik Mukherjee. April 11  - Australian shares closed lower on Friday, ending a turbulent week dominated by U.S.-China trade tensions, as tit-for-tat tariffs fuelled global uncertainty and dented market sentiment.The S&P/ASX 200 index .AXJO ended 0.8% down at 7,646.5. The benchmark lost 0.3% for the week, its second consecutive weekly fall. Investors weathered a tumultuous week after U.S. tariffs took effect, only to be abruptly paused by President Donald Trump, with China notably excluded from the reprieve. The temporary reprieve sparked a sigh of relief on Thursday, but uncertainty surrounding trade policies soon crept in, eroding investor confidence.\"Trump's tariff pause relief rally stalled overnight as the reality set in that the imposts that remain in place still present a significant risk to g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nL3N3QP0F4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7135","BK7501","BK7142","CSL.AU","BHP.AU","BK7508","BK7095","BK7511","CBA.AU","WDS.AU","BK7507"],"gpt_icon":0},{"id":"2526500507","title":"Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2526500507","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526500507?lang=en_us&edition=fundamental","pubTime":"2025-04-11 13:30","pubTimestamp":1744349419,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. At the time of writing, the benchmark index is down 1.2% to 7,616.6 points. Four ASX share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/11/why-antipa-imricor-lynas-and-newmont-shares-are-pushing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK7007","AUMC","BK7503","BK7095","BK7507","BK7504","IGO.AU","XJO.AU","BK7104","LYC.AU","NEM.AU","BK7506","BK4168","AZY.AU","IMR.AU"],"gpt_icon":0},{"id":"2526572552","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526572552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526572552?lang=en_us&edition=fundamental","pubTime":"2025-04-11 10:41","pubTimestamp":1744339260,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Friday.Monash IVF Group : -25%, AU$0.81Litchfield Minerals : -23%, AU$0.115Tlou Energy : -21%, AU$0.019Alara Resources : -18%, AU$0.023West Cobar Metals : -13%, AU$0.013Swoop Holdings : -13%, AU$0.105Atlantic Lithium : -12%, AU$0.15New Zealand King Salmon Investments : -12%, AU$0.19Comms Group : -12%, AU$0.046Opyl : -11%, AU$0.024","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK7142","A11.AU","SWP.AU","OPL.AU","BK7129","CCG.AU","BK7508","BK7042","WC1.AU","BK7141","LMS.AU","MVF.AU","NZK.AU","BK7016","TOU.AU","BK7113","AUQ.AU"],"gpt_icon":0},{"id":"2526574080","title":"Australia's Monash IVF admits 'error' after woman gives birth in embryo swap","url":"https://stock-news.laohu8.com/highlight/detail?id=2526574080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526574080?lang=en_us&edition=fundamental","pubTime":"2025-04-11 10:39","pubTimestamp":1744339187,"startTime":"0","endTime":"0","summary":"Australia's Monash IVF admits 'error' after woman gives birth in embryo swapBy Byron Kaye and Aaditya GovindRaoApril 11 (Reuters) - One of Australia's biggest IVF providers said it accidentally implan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nL3N3QP034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1169590202.USD","NWSA","BK4111","BK7508","BK7113","LU1169589451.USD","BK4588","MVF.AU"],"gpt_icon":0},{"id":"2526573849","title":"BRIEF-Mayne Pharma Served With Legal Proceeding Filed Against One Of Its US Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2526573849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526573849?lang=en_us&edition=fundamental","pubTime":"2025-04-11 09:28","pubTimestamp":1744334919,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Served With Legal Proceeding Filed Against One Of Its US SubsidiariesApril 11 (Reuters) - Mayne Pharma Group Ltd MYX.AX:SERVED WITH LEGAL PROCEEDING FILED AGAINST ONE OF ITS US SUBS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QO1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2526052029","title":"BUZZ-Australia's Monash IVF drops after embryo mix-up in clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2526052029","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526052029?lang=en_us&edition=fundamental","pubTime":"2025-04-11 09:10","pubTimestamp":1744333855,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Monash IVF drops after embryo mix-up in clinic** Shares of Monash IVF MVF.AX fall 21.9% to A$0.84 — biggest intraday percentage loss since mid August 2019** The fertility services provider confirmed on Tuesday, after-market hours, an incident in its Brisbane clinic related to a patient's embryo transferred to the wrong patient, resulting in the birth of a child** About 3.3 million shares change hands by 0052 GMT, 3.4 times the 30-day average volume of shares** Stock down 15.4% this year, as of last close","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nL3N3QP02X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7113","MVF.AU","BK7508"],"gpt_icon":0},{"id":"2526524680","title":"Hearts and Minds Investments Portfolio Falls Nearly 9% in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2526524680","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526524680?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:19","pubTimestamp":1744330743,"startTime":"0","endTime":"0","summary":"Hearts and Minds Investments'  portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.The investment company also saw the unsuccessful outcome of Opthea's  phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts & Minds to write down its investment to zero.Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","OPT.AU","HM1.AU","OPT","BK4139","BK7508"],"gpt_icon":0},{"id":"2526521062","title":"Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2526521062","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526521062?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:13","pubTimestamp":1744330432,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  started the VISABL-VT clinical trial after performing the first-in-human ventricular ablation guided by real-time interventional cardiac magnetic resonance  at the Amsterdam University Medical Center, according to a Friday filing with the Australian bourse.The trial evaluates the safety and effectiveness of radiofrequency ablation of ventricular tachycardia in ischemic cardiomyopathy using the Vision-MR Ablation Catheter 2.0 in the iCMR environment.The patient was treated for both right-sided and left-sided premature ventricular complexes, the filing said.Ventricular ablation is a procedure used to treat ventricular tachycardia, a rapid, abnormal heartbeat.Price : $1.36, Change: $+0.18, Percent Change: +14.83%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2526521776","title":"Mayne Pharma Group Served With Legal Proceedings Against US Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2526521776","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526521776?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:08","pubTimestamp":1744330111,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said that it has been served with a legal proceeding filed in the US District Court of Delaware against its US unit, Mayne Pharma, according to a Friday filing with the Australian bourse.The lawsuit filed by US-based women's healthcare company TherapeuticsMD  alleges breach of contract, fraudulent inducement, and unjust enrichment related to the 2022 transaction agreement between the companies, the filing said.The company plans to vigorously defend the case, which it believes is without merit, the filing added.MYX also stated it had separate claims against TXMD, alleging damages exceeding TXMD's claims.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","TXMD","BK7508","BK4007","BK7096"],"gpt_icon":0},{"id":"2526526916","title":"Mayne Pharma Group - Proceeding Is Brought by TherapeuticsMD, Inc. (Txmd) as Plaintiff","url":"https://stock-news.laohu8.com/highlight/detail?id=2526526916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526526916?lang=en_us&edition=fundamental","pubTime":"2025-04-11 07:28","pubTimestamp":1744327682,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QO1T1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2526526913","title":"Mayne Pharma - Served With Legal Proceeding Filed Against One of Its US Subsidiaries, Mayne Pharma Llc, in United States District Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2526526913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526526913?lang=en_us&edition=fundamental","pubTime":"2025-04-11 07:28","pubTimestamp":1744327682,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QO1T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2526152691","title":"Mayne Pharma Group -  Proceeding Alleges Breach of Contract, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2526152691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526152691?lang=en_us&edition=fundamental","pubTime":"2025-04-11 07:28","pubTimestamp":1744327682,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QO1T1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2526540145","title":"Immuron Travelan® Highest Sales in History","url":"https://stock-news.laohu8.com/highlight/detail?id=2526540145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526540145?lang=en_us&edition=fundamental","pubTime":"2025-04-11 06:00","pubTimestamp":1744322400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA21C3HM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":128,"code":"91000000","status":"200"}]}}